Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hammer

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|April 26, 2022
Coming of Age: Human Genomics and the Cancer-Immune Set PointChristian Hammer, Ira Mellman
Nature Reviews. Cancer|March 22, 2021
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasionSuchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Pharmacogenomics|May 10, 2008
Serotonin type 3 receptor genes: HTR3A, B, C, D, EBeate Niesler, Johannes Kapeller, Christian Hammer, et al.
Frontiers in Genetics|August 15, 2018
Correcting for Population Stratification Reduces False Positive and False Negative Results in Joint Analyses of Host and Pathogen GenomesOlivier Naret, Nimisha Chaturvedi, Istvan Bartha, et al.
Pharmacogenetics and Genomics|August 14, 2008
Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptorsJutta Walstab, Christian Hammer, Heinz Bönisch, et al.
Genome Medicine|June 22, 2019
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approachZia Khan, Christian Hammer, Ellie Guardino, et al.
Clinical and Translational Science|March 9, 2022
Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitroChristian Hammer, Jane Ruppel, Lynn Kamen, et al.
HLA|February 6, 2026
HLA Class II Alleles Are Associated With Anti-Drug Antibodies in Ulcerative Colitis Patients Treated With EtrolizumabAshis Saha, Mark I McCarthy, Saloumeh K Fischer, et al.
Plos Computational Biology|July 6, 2021
MiDAS-Meaningful Immunogenetic Data at ScaleMaciej Migdal, Dan Fu Ruan, William F Forrest, et al.
Turkish Neurosurgery|September 6, 2016
Predictors for Recurrence of Chronic Subdural HematomaAlexander Hammer, Alexander Tregubow, Ghassan Kerry, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|April 26, 2022
Coming of Age: Human Genomics and the Cancer-Immune Set PointChristian Hammer, Ira Mellman
Nature Reviews. Cancer|March 22, 2021
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasionSuchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Pharmacogenomics|May 10, 2008
Serotonin type 3 receptor genes: HTR3A, B, C, D, EBeate Niesler, Johannes Kapeller, Christian Hammer, et al.
Frontiers in Genetics|August 15, 2018
Correcting for Population Stratification Reduces False Positive and False Negative Results in Joint Analyses of Host and Pathogen GenomesOlivier Naret, Nimisha Chaturvedi, Istvan Bartha, et al.
Pharmacogenetics and Genomics|August 14, 2008
Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptorsJutta Walstab, Christian Hammer, Heinz Bönisch, et al.
Genome Medicine|June 22, 2019
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approachZia Khan, Christian Hammer, Ellie Guardino, et al.
Clinical and Translational Science|March 9, 2022
Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitroChristian Hammer, Jane Ruppel, Lynn Kamen, et al.
HLA|February 6, 2026
HLA Class II Alleles Are Associated With Anti-Drug Antibodies in Ulcerative Colitis Patients Treated With EtrolizumabAshis Saha, Mark I McCarthy, Saloumeh K Fischer, et al.
Plos Computational Biology|July 6, 2021
MiDAS-Meaningful Immunogenetic Data at ScaleMaciej Migdal, Dan Fu Ruan, William F Forrest, et al.
Turkish Neurosurgery|September 6, 2016
Predictors for Recurrence of Chronic Subdural HematomaAlexander Hammer, Alexander Tregubow, Ghassan Kerry, et al.
Pageof 6